• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肿瘤中驱动蛋白家族成员C1(KIFC1)的综合泛癌分析

An Integrative Pan-Cancer Analysis of Kinesin Family Member C1 (KIFC1) in Human Tumors.

作者信息

Wu Hao, Duan Yingjuan, Gong Siming, Zhu Qiang, Liu Xuanyou, Liu Zhenguo

机构信息

Center for Precision Medicine and Division of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, MO 65212, USA.

Faculty of Chemistry and Mineralogy, University of Leipzig, 04103 Leipzig, Germany.

出版信息

Biomedicines. 2022 Mar 10;10(3):637. doi: 10.3390/biomedicines10030637.

DOI:10.3390/biomedicines10030637
PMID:35327439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8945479/
Abstract

Kinesin family member C1 (KIFC1) is a minus-end-directed motor protein that is critically involved in microtubule crosslinking and spindle formation. KIFC1 is essential for supernumerary centrosomes, and it is associated with the initiation and progression of cancers. In the present study, we initially reviewed the The Cancer Genome Atlas database and observed that is abundantly expressed in most types of tumors. We then analyzed the gene alteration profiles, protein expressions, prognoses, and immune reactivities of KIFC1 in more than 10,000 samples from several well-established databases. In addition, we conducted a gene set enrichment analysis to investigate the potential mechanisms for the roles of in carcinogenesis. The pan-cancer analysis of KIFC1 demonstrates significant statistical correlations of the KIFC1 expression with the clinical prognoses, the oncogenic signature gene sets, the myeloid-derived suppressor cell infiltration, the ImmunoScore, the immune checkpoints, the microsatellite instabilities, and the tumor mutational burdens across multiple tumors. These data may provide important information on the understanding of the role and mechanisms of KIFC1 in carcinogenesis and immunotherapy, as well as on the clinical progression of a variety of cancers.

摘要

驱动蛋白家族成员C1(KIFC1)是一种向微管负端移动的驱动蛋白,在微管交联和纺锤体形成中起关键作用。KIFC1对于多余中心体至关重要,并且与癌症的发生和发展相关。在本研究中,我们首先查阅了癌症基因组图谱数据库,发现其在大多数肿瘤类型中均有大量表达。然后,我们分析了来自几个成熟数据库的一万多个样本中KIFC1的基因改变图谱、蛋白表达、预后及免疫反应性。此外,我们进行了基因集富集分析,以探究其在致癌作用中的潜在机制。KIFC1的泛癌分析表明,KIFC1表达与多种肿瘤的临床预后、致癌特征基因集、髓源性抑制细胞浸润、免疫评分、免疫检查点、微卫星不稳定性及肿瘤突变负荷之间存在显著的统计学相关性。这些数据可能为理解KIFC1在致癌作用和免疫治疗中的作用及机制,以及各种癌症的临床进展提供重要信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/f7e2809d3c8b/biomedicines-10-00637-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/d0e2bf8957a2/biomedicines-10-00637-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/5c203ff73a56/biomedicines-10-00637-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/2fc80cdc6067/biomedicines-10-00637-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/6448b19953ec/biomedicines-10-00637-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/c809bcd6a2f3/biomedicines-10-00637-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/018950793879/biomedicines-10-00637-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/02de4d860c76/biomedicines-10-00637-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/f7e2809d3c8b/biomedicines-10-00637-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/d0e2bf8957a2/biomedicines-10-00637-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/5c203ff73a56/biomedicines-10-00637-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/2fc80cdc6067/biomedicines-10-00637-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/6448b19953ec/biomedicines-10-00637-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/c809bcd6a2f3/biomedicines-10-00637-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/018950793879/biomedicines-10-00637-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/02de4d860c76/biomedicines-10-00637-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d74/8945479/f7e2809d3c8b/biomedicines-10-00637-g008.jpg

相似文献

1
An Integrative Pan-Cancer Analysis of Kinesin Family Member C1 (KIFC1) in Human Tumors.人肿瘤中驱动蛋白家族成员C1(KIFC1)的综合泛癌分析
Biomedicines. 2022 Mar 10;10(3):637. doi: 10.3390/biomedicines10030637.
2
Multi-omics analysis of kinesin family member 2C in human tumors: novel prognostic biomarker and tumor microenvironment regulator.人类肿瘤中驱动蛋白家族成员2C的多组学分析:新型预后生物标志物和肿瘤微环境调节因子
Am J Cancer Res. 2022 Nov 15;12(11):4954-4976. eCollection 2022.
3
A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer.泛癌中 KIFC1 的预后和免疫治疗特征的综合分析及其在胰腺癌恶性表型中的作用。
Aging (Albany NY). 2023 Dec 18;15(24):14845-14863. doi: 10.18632/aging.205311.
4
High KIFC1 expression is associated with poor prognosis in prostate cancer.KIFC1 高表达与前列腺癌预后不良相关。
Med Oncol. 2021 Mar 24;38(5):47. doi: 10.1007/s12032-021-01494-x.
5
KIFC1 is essential for bipolar spindle formation and genomic stability in the primary human fibroblast IMR-90 cell.驱动蛋白家族成员C1(KIFC1)对于原代人成纤维细胞IMR-90中的双极纺锤体形成和基因组稳定性至关重要。
Cell Struct Funct. 2013;38(1):21-30. doi: 10.1247/csf.12014. Epub 2013 Jan 11.
6
KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.KIFCI,一种新型的卵巢腺癌潜在预后生物标志物:描绘蛋白质相互作用网络和信号通路。
J Ovarian Res. 2014 May 12;7:53. doi: 10.1186/1757-2215-7-53. eCollection 2014.
7
Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.驱动蛋白家族成员C1在各种癌症中的预后及临床病理意义:一项荟萃分析
Medicine (Baltimore). 2019 Oct;98(40):e17346. doi: 10.1097/MD.0000000000017346.
8
Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.驱动蛋白家族成员 C1 通过 Akt/GSK3β 信号通路加速膀胱癌的增殖并诱导上皮间质转化。
Cancer Sci. 2019 Sep;110(9):2822-2833. doi: 10.1111/cas.14126. Epub 2019 Jul 23.
9
KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.KIFC1 受 TCF-4 激活,并通过调节 HMGA1 的转录活性促进肝癌的发病机制。
J Exp Clin Cancer Res. 2019 Jul 24;38(1):329. doi: 10.1186/s13046-019-1331-8.
10
Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1.小分子运动蛋白 KIFC1 抑制剂的发现和作用机制研究。
ACS Chem Biol. 2013 Oct 18;8(10):2201-8. doi: 10.1021/cb400186w. Epub 2013 Aug 16.

引用本文的文献

1
Targeting Kinesins for Therapeutic Exploitation of Chromosomal Instability in Lung Cancer.靶向驱动蛋白以治疗性利用肺癌中的染色体不稳定
Cancers (Basel). 2025 Feb 18;17(4):685. doi: 10.3390/cancers17040685.
2
The kinesin Kar3 is required for endoplasmic reticulum-associated degradation.驱动蛋白Kar3是内质网相关降解所必需的。
Mol Biol Cell. 2025 Mar 1;36(3):br9. doi: 10.1091/mbc.E24-10-0437. Epub 2025 Jan 22.
3
Kinesin Family Member C1: Function in liver hepatocellular carcinoma and potential target for chemotherapeutic.

本文引用的文献

1
KIFC1 Regulates the Trajectory of Neuronal Migration.KIFC1 调控神经元迁移轨迹。
J Neurosci. 2022 Mar 16;42(11):2149-2165. doi: 10.1523/JNEUROSCI.1708-21.2022. Epub 2022 Jan 19.
2
KIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer.KIFC1与膀胱癌的基底型、顺铂耐药、PD-L1表达及不良预后相关。
J Clin Med. 2021 Oct 21;10(21):4837. doi: 10.3390/jcm10214837.
3
High KIFC1 expression is associated with poor prognosis in prostate cancer.KIFC1 高表达与前列腺癌预后不良相关。
驱动蛋白家族成员C1:在肝细胞癌中的作用及化疗潜在靶点
Heliyon. 2024 Sep 11;10(18):e37832. doi: 10.1016/j.heliyon.2024.e37832. eCollection 2024 Sep 30.
4
Microtubule-Targeting Agents: Disruption of the Cellular Cytoskeleton as a Backbone of Ovarian Cancer Therapy.微管靶向药物:作为卵巢癌治疗骨干的细胞细胞骨架破坏。
Adv Exp Med Biol. 2024;1452:1-19. doi: 10.1007/978-3-031-58311-7_1.
5
A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer.泛癌中 KIFC1 的预后和免疫治疗特征的综合分析及其在胰腺癌恶性表型中的作用。
Aging (Albany NY). 2023 Dec 18;15(24):14845-14863. doi: 10.18632/aging.205311.
Med Oncol. 2021 Mar 24;38(5):47. doi: 10.1007/s12032-021-01494-x.
4
Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention.剪接因子通过 SUN2 相互作用和 sororin 内含子保留控制三阴性乳腺癌细胞有丝分裂。
J Exp Clin Cancer Res. 2021 Mar 1;40(1):82. doi: 10.1186/s13046-021-01863-4.
5
Kinesin Family Member C1 Increases Temozolomide Resistance of Glioblastoma Through Promoting DNA Damage Repair.驱动蛋白家族成员 C1 通过促进 DNA 损伤修复增加胶质母细胞瘤对替莫唑胺的耐药性。
Cell Transplant. 2021 Jan-Dec;30:963689721991466. doi: 10.1177/0963689721991466.
6
Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells.髓源性抑制细胞通过 CCL11 促进肺癌转移,从而激活 ERK 和 AKT 信号通路,并诱导肿瘤细胞上皮-间充质转化。
Oncogene. 2021 Feb;40(8):1476-1489. doi: 10.1038/s41388-020-01605-4. Epub 2021 Jan 15.
7
The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation.ATM和ATR激酶通过靶向KIFC1磷酸化来调节中心体聚集和肿瘤复发。
Nat Commun. 2021 Jan 4;12(1):20. doi: 10.1038/s41467-020-20208-x.
8
miR-635 targets KIFC1 to inhibit the progression of gastric cancer.miR-635 靶向 KIFC1 抑制胃癌的进展。
J Investig Med. 2020 Dec;68(8):1357-1363. doi: 10.1136/jim-2020-001438. Epub 2020 Aug 4.
9
KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma.KIF2C:在肝细胞癌发病机制中 Wnt/β-连环蛋白和 mTORC1 信号之间的新联系。
Protein Cell. 2021 Oct;12(10):788-809. doi: 10.1007/s13238-020-00766-y. Epub 2020 Aug 3.
10
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.肿瘤微环境和上皮间质转化作为克服肿瘤多药耐药的靶点。
Drug Resist Updat. 2020 Dec;53:100715. doi: 10.1016/j.drup.2020.100715. Epub 2020 Jun 20.